Series of domestic pharmaceuticals’ approvals to start global Phase 1 clinical trials
Domestic pharmaceutical companies are actively attempting to expand to the U.S. and European markets.
According to the industry concerned on the 10th, a series of news have continued about Phase 1 clinical trials over a number of companies’ new drugs and drug candidates.
Chong Kun Dang acquired...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
